Low 17.5 and 2nd tranche also done !!

Now sit calm and enjoy the Chip later. 😊

Happy?

Average price 20 and now 28.

Already 40% gains. 😊

#Update
#Crypto
#Takeoutcapital

VVV - 10$ to 20$

Another Paisa double from Chartbank. Take out capital and hold free coins.

Closing above 21$ will give fresh breakout.

#Update
#NYSE

Fedex - 330 to 413++

25% done and a fresh breakout now. Hold tight. 😊

#Freshview
#NYSE

CADL - 9.40$, 4th June, 2026.

Looking good for 14++

Closing above 15 will give a big breakout for a multibagger. 👍

Go with a small quantity. This is high risk high return stock.

Candel Therapeutics is a clinical-stage biotechnology company developing viral immunotherapies for cancer treatment. Its lead candidate, CAN-2409 (aglatimagene besadenovec), has shown positive Phase 3 results in localized prostate cancer and is advancing toward regulatory submission. The company also has programs in lung cancer, pancreatic cancer, and glioma.

CADL is a high-risk, high-reward biotech. The investment thesis largely depends on successful approval and commercialization of CAN-2409. If approval occurs, today's valuation could look inexpensive; if not, the downside can be substantial.

Key Growth Catalysts

- Potential BLA submission in Q4 2026 for CAN-2409 in prostate cancer.

-Positive Phase 3 data showing improved disease-free survival.

- FDA support through Fast Track, RMAT, and Special Protocol Assessment.

- Potential expansion into NSCLC and other solid tumors

#Update
#NYSE

Reddit - 164 to 187++

Moving as per plan !!